Activity of tesetaxel, an oral taxane, given as a single-agent in patients (Pts) with HER2-, hormone receptor + (HR+) locally advanced or metastatic breast cancer (MBC) in a phase 2 study Meeting Abstract
| Authors: | Seidman, A. D.; Schwartzberg, L. S.; Gudena, V. K.; Rubin, P.; Kroll, S.; O'Connell, J. P.; Tang, K.; O'Shaughnessy, J. |
| Abstract Title: | Activity of tesetaxel, an oral taxane, given as a single-agent in patients (Pts) with HER2-, hormone receptor + (HR+) locally advanced or metastatic breast cancer (MBC) in a phase 2 study |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 44s |
| Language: | English |
| ACCESSION: | WOS:000442916001064 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.1042 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1042 -- Source: Wos |
